Alkermes plc buy melinda
Start price
18.10.17
/
50%
€46.34
Target price
27.10.17
€49.61
Performance (%)
7.49%
End price
27.10.17
€49.82
Summary
This prediction ended on 27.10.17 with a price of €49.82. The BUY prediction by melinda finished with a performance of 7.49%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Alkermes plc | 4.630% | 4.630% | -21.528% | 15.306% |
iShares Core DAX® | -3.033% | 0.651% | 12.268% | 18.187% |
iShares Nasdaq 100 | -3.554% | -3.007% | 27.682% | 47.279% |
iShares Nikkei 225® | -3.938% | 1.935% | 10.515% | 10.489% |
iShares S&P 500 | -1.517% | -0.602% | 25.859% | 45.572% |
Comments by melinda for this prediction
In the thread Alkermes plc diskutieren
Biotechnologie und medizinische SecteurRecherche
Neue Studie zur Bewertung der Wirksamkeit von extended-release Naltrexon mit Buprenorphin-Naloxon für Opiatabhängigkeit Veröffentlicht in JAMA Psychiatrie Vergleich
(Zielkurs erreicht)